Resources from the same session
Leveraging the molecular biology of hepatocellular carcinoma (HCC) in optimising response to immunotherapy
Presenter: Stephen Chan
Session: Leveraging the molecular biology of gastrointestinal cancers for optimal benefit from immunotherapeutic approaches
Resources:
Slides
Webcast
Enhancing immunotherapy responsiveness in squamous versus adenocarcinoma based on molecular biology (focus on primarily esophageal cancer)
Presenter: Brian Henick
Session: Leveraging the molecular biology of gastrointestinal cancers for optimal benefit from immunotherapeutic approaches
Resources:
Slides
Webcast
Immunotherapy in microsatellite stable (MSS) luminal gastrointestinal cancers
Presenter: Hanneke van Laarhoven
Session: Leveraging the molecular biology of gastrointestinal cancers for optimal benefit from immunotherapeutic approaches
Resources:
Slides
Webcast